Updates are available Erratum dated 2014-12-05
Click to view Erratum: https://doi.org/10.1038/hr.2014.147
-
Authors
Rakugi, Hiromi
Tsuchihashi, Takuya
Shimada, Kazuyuki
Numaguchi, Hirotaka
Nishida, Chisato
Yamaguchi, Hiroya
Fujimoto, Go
Azuma, Kyoichi
Shirakawa, Masayoshi
Hanson, Mary E
Fujita, Kenji P
- License Information
-
More Information
Article History
Received: 28 February 2014
Revised: 30 April 2014
Accepted: 3 May 2014
First Online: 3 July 2014
Competing interests
: HR received honoraria and/or fees for promotional materials from Astellas Pharma, Daiichi Sankyo, Kyowa Hakko Kirin, Nippon Boehringer Ingelheim, Novartis Pharma and Takeda Pharmaceutical and received research funding from Astellas Pharma, Daiichi Sankyo, Kyowa Hakko Kirin, Mitsubishi Tanabe Pharma, MSD KK, Nippon Boehringer Ingelheim, Novartis Pharma, Pfizer Japan and Takeda Pharmaceutical. TT received honoraria and/or fees for promotional materials from Dainippon-Sumitomo and MSD KK and received research funding from MSD KK. KS received honoraria and/or fees for promotional materials from Daiichi Sankyo, Dainippon-Sumitomo, MSD KK, Novartis and Takeda Pharmaceutical. HN, CN, HY, GF, KA and MS are employees of MSD KK. MEH and KF are employees of Merck and may own stock or hold stock options in the company.
Free to read: This content has been made available to all.
